NO impact on cell energy and LIP, 2 Abstract: Microglial activation is common in several neurodegenerative disorders. In the present study, we used the murine BV-2 microglial cell line stimulated with γ-interferon and lipopolysaccharide to gain new insights into the effects of endogenously produced NO on mitochondrial respiratory capacity, iron regulatory protein activity, and redox-active iron level. Using polarographic measurement of respiration of both intact and digitoninpermeabilized cells, and spectrophotometric determination of individual respiratory chain complex activity, we showed that in addition to the reversible inhibition of cytochrome-c oxidase, long-term endogenous NO production reduced complex I and complex II activities in an irreversible manner. As a consequence, the cellular ATP level was decreased in NO-producing cells, whereas ATPase activity was unaffected. We show that NO up-regulates RNA-binding of iron regulatory protein 1 in microglial cells, and strongly reduces the labile iron pool. Together these results point to a contribution of NO derived from inflammatory microglia to the misregulation of energy-producing reactions and iron metabolism, often associated with the pathogenesis of neurodegenerative disorders.
INTRODUCTION
Microglial activation, oxidative stress, impairment of mitochondrial energy metabolism, and intracellular iron accumulation are features common to several neurodegenerative disorders (Beal, 1998; Hirsch, 2000; Murphy, 2000; Schapira, 1999) .
There is a consensus that these metabolic dysfunctions play an important part in the pathophysiology of these diseases, but their interplay is complex and difficult to define.
Even though the major physiological roles of microglial cells are host defense and tissue repair by phagocytosis, when activated they can also generate high levels of inflammatory cytokines, nitric oxide (NO) and reactive oxygen species (ROS), which may exacerbate neuronal damage (Gonzalez-Scarano and Baltuch, 1999; Nakajima and Kohsaka, 1998; Stoll and Jander, 1999) . Therefore, in Alzheimer's disease (AD), microglia proliferate around the pathological lesions and are believed to be important in plaque formation and neuronal degeneration (Gonzalez-Scarano and Baltuch, 1999; Lee et al., 1999; Wa et al., 1996) . Microglial activation and accumulation also occur in Parkinson's disease (PD) (McGeer et al., 1988; Hirsch, 2000) and in animal models of neurodegeneration (Calingasan et al., 1998; Kurkowska-Jastrzebska et al., 1999; Liberatore et al., 1999) . NO, a signaling molecule responsible for a large number of physiological functions, may be harmful when produced in excessive concentrations and its implication in many neurodegenerative diseases has been suggested (Dawson and Dawson, 1998; Heales et al., 1999; Hirsch, 2000; Murphy, 2000; Toreilles et al., 1999) . NO and/or peroxynitrite, a strong oxidant generated from the combination of NO and O 2 -, inhibit(s) several mitochondrial enzymes, including complexes of the respiratory chain and the Krebs cycle enzyme aconitase (Drapier, 1997; Clementi et al., 1998; Brown, 1999) . Moreover, in parallel to impairment of mitochondrial functions, a marked dysregulation of iron
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metabolism is also a feature common to many neurodegenerative disorders including PD, AD and Friedreich's ataxia (FA) (Bradley et al., 2000; Delatycki et al., 1999; Hirsch and Faucheux, 1998; Rötig et al., 1997; Schapira, 1999; Smith et al., 1997; Smith et al., 1998) . Strikingly, NO production is responsible for alteration of iron metabolism in many cell types, and recent results including ours pointed to a drastic change in iron regulatory protein (IRP) activity induced by NO and peroxynitrite, especially in macrophages (reviewed in Drapier et al., 2000) . We consider here whether NO generated by microglial cells exposed to inflammatory stimuli alters these cells' mitochondrial and iron metabolisms. We found that NO production is responsible for alteration of specific sites of the electron transport chain associated with reduced ATP. In addition, we show for the first time that RNA-binding of IRP-1 is up-regulated by NO in microglial cells and that their labile iron pool (LIP) is decreased in an NO-dependent manner.
MATERIALS AND METHODS

Materials
Murine recombinant γ-interferon (IFN-γ, specific activity 2 x 10 7 units/mg) was 
Cell culture
The BV-2 murine microglial cell line established by Blasi et al., 1990 was kindly supplied by Dr. C. Demerlé-Pallardy (Institut Henri Beaufour, Les Ulis, France). Cells were routinely cultured in DMEM containing 1 g/l glucose, sodium pyruvate, pyridoxine, glutamax, and gentamycin antibiotic, and complemented with 10% fetal calf serum (FCS).
For NO synthase (NOS) induction, semi-confluent cells were treated with 20 U/ml IFN-γ and 50 ng/ml LPS for 16 h.
Preparation of mitochondrial and cytosolic fractions
Cells were detached, washed once in phosphate buffered saline (PBS) and centrifuged at 400 x g for 10 min. Cells were resuspended in 0.25 M sucrose, 40 mM KCl, 2 mM EGTA, 20 mM TRIS, pH 7.2, and lysed with 0.007% digitonin for 5 min on ice.
After centrifugation at 1,800 x g for 10 min, cytosol-free pellets (3 mg protein/ml) were dried and frozen at -80°C and were referred to as the mitochondrial fraction. Collected supernatants were ultracentrifuged at 150,000 x g for 60 min and the resultant cytosolic extracts (0.5 mg protein/ml) were kept at -80°C. The lactate dehydrogenase (LDH) and cytochrome-c oxidase (COX) activities were measured spectrophotometrically as markers of the cytoplasmic and mitochondrial fractions, respectively. The LDH activity was measured by the decline of NADH oxidation at 340 nm by using a commercially available kit (LD-L10, Sigma Diagnostics). LDH activity in the mitochondrial fraction was below 5% of total LDH activity (cytoplasmic + mitochondrial fraction) indicating that very little hal-00422911, version 1 -8 Oct 2009
cytoplasmic material remained in the mitochondrial fraction. Conversely, the 95% of COX activity, which was measured as described below, was found in the mitochondrial fraction.
Polarographic measurement of cellular respiration and electron transport chain (ETC) activities
Oxygen consumption was measured with a Clarke-type electrode in a Peltiercontrolled chamber (Hansatech oxytherm, EUROSEP, Cergy-St-Christophe, France).
Polarography was used to determine activity of specific segments of the ETC using digitonin-permeabilized cells (1x10 7 cells/ml) in 0.25 M sucrose, 10 mM MgCl 2 , 2 mM KH 2 PO 4 , 1 mM EGTA, 7% BSA, 0.005% digitonin, 20 mM HEPES pH 7.2, as previously described (Drapier and Hibbs, 1988) . Appropriate substrates and inhibitors were added as indicated. Acceptor control ratio was ~3.
Spectrophotometric determination of ETC activities
The activity of each complex of the ETC was assayed spectrophotometrically in the mitochondrial fraction (30 µg protein) as previously described (Rustin et al., 1994; Trounce et al., 1996) . All enzymatic activities were measured at 37°C with a SAFAS UVmc2 spectrophotometer equipped with multikinetic analysis software (SAFAS, Monaco). Complex I, NADH-ubiquinone reductase, activity was followed through the decline of NADH oxidation at 340 nm in the presence of decylubiquinone as an electron acceptor. Complex II, succinate-ubiquinone reductase, activity was determined by the reduction of the electron donor 2,6-dichloroindophenol at 600 nm in the presence of oxidation of reduced cytochrome-c at 550 nm. Complex V, ATPase, activity was determined by coupling the reaction to a pyruvate kinase and LDH system, and followed by monitoring the decline of NADH oxidation at 340 nm.
Electrophoretic mobility shift assay (EMSA)
The IRP-IRE interaction was analyzed as described (Drapier and Hibbs, 1996) , by incubating 2 µg protein of cell lysates with a molar excess of 32 P-CTP-labeled ferritin IRE probe in 20 µl of 10 mM HEPES (pH 7.6), 40 mM KCl, 3 mM MgCl 2 , and 5% glycerol. In parallel experiments, samples were treated with 2% 2-mercaptoethanol before addition of the RNA probe to allow full expression of the IRE binding activity. After a 20-min incubation at room temperature, 1 µl of RNase T1 (1 unit/µl) and 2 µl of heparin (50 mg/ml) were sequentially added for 10 min each. The IRP-IRE complexes were resolved on 6% non-denaturing polyacrylamide gels and were quantified with the IMAGEQUANT software from Molecular Dynamics (Amersham-Pharmacia Biotech, Orsay, France).
Determination of the labile iron pool (LIP)
LIP was determined by spectrofluorimetry as previously described (Epsztejn et al., 1997) with slight modifications. Briefly, 2.10 6 cells were resuspended in 2 ml of prewarmed 20 mM HEPES, pH 7.3, 150 mM NaCl, 1% BSA buffer, and were incubated with 50 nM calcein-AM for 15 min at 37°C. After centrifugation and washing, cells were resuspended in the same buffer, and the calcein fluorescence intensity was recorded as a function of time. A stable baseline signal was recorded for 60 sec before the addition of 100 µM SIH, a highly permeant iron chelator, which caused a rise in fluorescence corresponding to the LIP. LIP concentration was calibrated and calculated as described (Epsztejn et al., 1997) . The excitation and emission wavelengths were 483 nm and 505 nm, respectively.
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Cytochrome-c immunostaining 
Lactate measurement
BV2 cells were cultured in DMEM + 10% FCS for 16 hours. At this time, the culture medium was removed and the incubation continued with fresh medium for 5 hours.
The medium was then removed, centrifuged, and aliquots of culture medium were assayed for lactate by monitoring the oxidation of L-lactic acid to pyruvate by NAD in the presence of lactate dehydrogenase (Sigma). NADH formation was monitored at 340 nm.
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Other assays
The accumulation of the NO-end product nitrite in the culture media was determined spectrophotometrically at 543 nm by using the Griess reagent with final concentrations of 0.5% sulfanilamide and 0.05% N-(1-naphthyl)ethylenediamine hydrochloride in 45% acetic acid. The intracellular ATP was measured in cell lysates by chemiluminescence with the ATP-bioluminescence-assay-kit HS-II (Roche Diagnostics, Meylan, France) and following the supplier's instructions. Aconitase activity was measured in both cytoplasmic and mitochondrial fractions by following the disappearance of cis-aconitate at 240 nm at 37°C as described previously (Drapier and Hibbs, 1996) .
Units are nmoles of substrate consumed/min. The protein content of both the mitochondrial fraction and cytoplasmic extracts was determined at 595 nm by using the Bio-Rad protein assay with BSA as a standard.
Statistics
Data represent the mean the mean ± S.D. of at least three independent experiments.
Statistical significance was tested with one-way ANOVA with post-hoc Student-NewmanKeuls comparison (p<0.01 or p<0.05).
RESULTS
Stimulation of BV-2 microglial cells induces NO-synthesis and cytochrome-c release
The combination of 20 U/ml IFN-γ plus 50 ng/ml LPS was chosen because it induced a time-dependent NO production in the BV-2 cell line without triggering toxicity.
Nitrite accumulation in media was detectable as early as 4 h after stimulation, and the
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increase was subsequently linear for the next 20 h. Increasing IFN-γ and/or LPS concentration did not increase nitrite production, whereas lower concentrations were not fully efficient (data not shown). The NOS inhibitors L-NMMA (2 mM) and Sethylisothiourea (SEIT, 100 µM) reduced nitrite accumulation by an average of 82% and 90%, respectively (Fig. 1A) . In addition, nitrite production was fully inhibited by the NOS-2 specific inhibitors 1400W (100 µM) and L-NIL (500 µM). NOS activity was further assayed by the production of ( 3 H)-citrulline from ( 
FIG 1
NO-mediated inhibition of cellular respiration
The effect of NO production on the different segments of the ETC was studied in digitonin-permeabilized cells to which were added exogenous substrates and selective inhibitors of the different complexes which compose the chain. The oxygen consumption rate in state 3, which is dependent on either complex I (malate/glutamate as substrates) or complex II (succinate as substrate in the presence of rotenone), was substantially decreased in permeabilized cells which had been previously exposed to IFN-γ plus LPS (Fig. 2) . BV2
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cells stimulated in the presence of L-NMMA, an inhibitor of NOS, did not exhibit such a decrease.
After cell permeabilization and in the absence of exogenously added L-arginine and NOS cofactors, the NO flux was stopped during the measurement of oxygen consumption rate. Therefore, in agreement with the fact that inhibition of complex IV activity by NO is reversible, the oxygen consumption using TMPD plus ascorbate as substrates was not markedly inhibited under these conditions (Fig. 2) .
FIG. 2
Inhibition of complexes I and II isolated activities by endogenous NO
The measurement of the activity of complexes I-III by O 2 consumption relies on the assumption that the downstream segment (complex IV) is not limiting. As the latter is sensitive to NO, it is worth measuring the activities of complexes I-III individually.
Accordingly, the precise site of the NO-dependent blockade in the respiratory chain was assessed by measuring the activity of each complex of the chain, by means of spectrophotometry using mitochondrial fractions prepared from control and stimulated BV-2 cells. The results depicted in Fig. 3 show that NO production by BV2 cells was associated with an average 45% inhibition of complex I and 59% inhibition of complex II.
In addition, the activity of complexes II + III was inhibited to the same extent (57%) than that of complex II, implying that complex III was left intact. Furthermore, in the mitochondrial fraction from cells previously stimulated in the presence of L-NMMA, the average activity of complexes I and II was 89% and 103% of the control, respectively ( cells, which can be explained, as mentioned above, by the absence of NO flux during the assay.
FIG. 3
NO-mediated decrease of intracellular ATP and mitochondrial aconitase activity
Intracellular ATP was measured in either control or NO-producing BV-2 cells.
ATP was decreased by an average of 67% in IFN-γ plus LPS treated cells and maintained at control level when L-NMMA was present during stimulation (Fig. 4A) . Nevertheless, ATPase activity was unchanged in the mitochondrial fraction from control and stimulated cells (Fig. 4B ), suggesting that energetic impairment occurred upstream of complex V.
In addition, the activity of the Krebs cycle enzyme aconitase was strongly inhibited in the mitochondrial fraction from NO-producing cells (1.11 ± 0.52 U/mg protein versus 42.36 ± 7.33 U/mg in control mitochondrial fraction, n=3, p<0.01). By contrast, the glycolysis pathway was not affected since lactate levels were not significantly changed in IFN-γ plus LPS treated cells (1.37 ± 0.08 mM versus 1.24 ± 0.18 mM in control cells medium, n=3, p>0.3).
FIG. 4
Increased IRE-binding activity of IRP-1 in NO-producing BV-2 cells
The effect of NO on IRP-1 and IRP-2 was investigated in the cytosol from control and IFN-γ plus LPS -γ-treated BV-2 cells by an EMSA. IRE-binding activity of IRP-1 was strongly increased in NO-producing BV-2 cells (Fig. 5) , and, as a counterpart, cytosolic aconitase activity of IRP-1 which was 100.85 ± 37.85 U/mg protein in control cytosol, was totally inhibited. The results of Fig. 5 also show that IRP-2 RNA binding was not significantly modified.
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FIG. 5
Decreased LIP in NO-producing BV-2 cells
Whether NO production and IRP-1 modulation affect intracellular iron and particularly the LIP was then assessed. LIP was determined by the method described by Epsztejn et al., 1997 
FIG. 6
DISCUSSION
There is accumulating evidence that activated glial cells, by producing inflammatory regulators like tumor necrosis factor, certain eicosanoids or nitrogen oxides, contribute to neuronal injury (Gonzalez-Scarano and Baltuch, 1999; Hirsch, 2000; Knott et al., 2000; Liberatore et al., 1999; Nakajima and Kohsaka, 1998) . For example, it has been shown that activation of microglia by β-amyloid peptide or inflammatory cytokines such as IFN-γ and interleukin-1β leads to high NO synthesis in rodents (Araujo and Cotman, 1992;  hal-00422911, version 1 -8 Oct 2009
well as in humans (Colasanti et al., 1995; Ding et al., 1997; Meda et al., 1995) . In this report, we focused on the relationship between NO synthesis in microglial cells and two parameters crucial for cell survival: mitochondrial metabolism and the level of redoxactive iron. Stimulation of BV2 microglial cells by a combination of IFN-γ and LPS induced NOS activity, and a marked flux of NO was released from cells for several hours.
Several metabolic dysregulations dealing with cellular iron-related functions and specific sites of mitochondrial energy production were observed.
Over the last twenty years, several approaches have been followed to assess the NO-dependent dysfunction of the mitochondrial respiration. Originally, cells were harvested and permeabilized before measuring the oxygen uptake by polarography. These experimental conditions allowed demonstration that complex I and complex II activities were significantly reduced soon after the beginning of physiological production of NO (Granger and Lehninger, 1982; Drapier and Hibbs, 1986; Drapier and Hibbs, 1988) . It was also noticed that electron flow was reversibly inhibited at the complex IV level (Brown, 1999; Heales et al., 1999) . Alternatively, each segment of the electron transport chain can be individually assessed by spectrophotometry (Rustin et al., 1994) to avoid possible caveats linked to measurement of oxygen consumption. Our present study combined these different approaches in the same experimental cell model. Our data underlined that persistent exposure of microglial cells to endogenous NO or derivatives led to reduction of complex I and complex II activities. Few reports have addressed the question of whether NO-dependent reduction of mitochondrial respiration is accompanied by inhibition of ATP synthesis. It has been recently reported that short exposure of brain cells to NO gas is responsible for reversible inhibition of ATP synthesis by mitochondria The pattern of metabolic dysfunctions we have described, i.e. inhibition of respiration, loss of mitochondrial aconitase activity or ATP depletion, is often associated with iron overload within neuronal cells. This proved true in the Parkinsonian substantia nigra (Gu et al., 1998; Hirsch and Faucheux, 1998; Schapira, 1999) , mitochondria of heart cells of FA patients (Bradley et al., 2000; Delatycki et al., 1999; Rötig et al., 1997) and hippocampus of AD patients (Smith et al., 1997 (Smith et al., , 1998 , and it has been proposed that oxidative stress triggered by iron accumulation could be responsible for the deficiency of the respiratory chain Fe-S enzymes (Rötig et al., 1997) . The pool of potentially toxic iron is finely tuned by two cytoplasmic regulatory proteins, namely iron regulatory proteins (IRP-1 and IRP-2). IRPs control, via binding to IRE or IRE-like motifs, the translation of proteins playing a relevant part in energy metabolism, namely the Krebs cycle aconitase, succinate dehydrogenase subunit b (at least in insect) and the 75 kDa subunit of complex I (Lin et al., 2001) , and of proteins involved in iron uptake or storage, like ferritin, transferrin receptor, divalent metal transporter (DMT) -1 (see Cairo and Pietrangelo, 2000 for a review). In BV-2 microglial cells, IRP1 contributes a higher proportion of total IRP activity. We showed that IRP-1 (but not IRP-2) activity was markedly increased in NOproducing BV2 cells, thus implying that IRE-containing mRNAs were subject to reduced translation or higher stability. NO-dependent modulation of IRPs that has previously been described in macrophages, neurons and fibroblasts (Drapier et al., 2000; Jaffrey et al., 1994; Pantopoulos and Hentze, 1995; Wardrop and Richardson, 2000) is reported here in microglial cells for the first time. A potential consequence of NO-dependent IRP-1
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activation in glial cells would be repression of ferritin which has an IRE in the 5' UTR of its mRNA, and increased stability of transferrin receptor mRNA which has 5 IREs in its 3' UTR. As a consequence, increased iron uptake coupled to lessened storage may contribute to the cell damage often seen in mitochondria-related neurological disorders (Hirsch and Faucheux, 1998; Rötig et al., 1997; Smith et al., 1998) .
It is worth stressing that IRP-1 is itself an aconitase which converts citrate into isocitrate in the cytosol. When activating the IRE-binding activity of IRP-1, NO inhibits its aconitase activity. The aconitase function of IRP-1 is still elusive but a recent genetic study in yeast pointed to a possible role of its aconitase activity in glutamate synthesis and in NADPH replenishment of the anti-oxidant systems glutathione and thioredoxin/thioredoxin reductase (Narahari et al., 2000) . It is likely that the aconitase form of IRP-1 contributes to NADPH production in partnership with the cytosolic NADP-dependent isocitrate dehydrogenase in resting (i.e. not producing NO) cells. We checked that NO synthesis in BV2 microglial cells also led to loss of mitochondrial aconitase. In mitochondria, isocitrate dehydrogenase allows regeneration of NADPH required for reduction of glutathione disulfide (Vogel et al., 1999) and thioredoxin reductase (Watabe et al., 1999) . Altogether, NO-dependent inhibition of cytosolic and mitochondrial aconitases, by limiting isocitrate supply, may contribute to modulation of the NADPH-dependent redox balance in both cell compartments.
A parameter relevant to oxidative stress and cellular iron homeostasis which often accompanies various neurological disorders is the fraction of intracellular iron that is not present in protein prosthetic groups or stored in ferritin. This pool of iron is still ill-defined but recent progress has been made in evaluating its level (Epsztejn et al., 1997) and it is now referred to as the labile iron pool or LIP. In this study, we showed that LIP reduction was dependent on NO synthesis and was even more pronounced than that exhibited by hal-00422911, version 1 -8 Oct 2009
deferroxamine-exposed cells. Such a 40% change of LIP level was as high as what has been previously reported in the literature in the case of regulation by ferritin (Kakhlon et al., 2001; Picard et al., 1998) . Interestingly, this NO-dependent LIP decrease was significantly different from control as early as 8 h after the beginning of the activation, i.e.
shortly after the beginning of significant NO production. This result indicates that LIP decrease is not the consequence of ferritin and transferrin receptor modulation through the IRP/IRE system. Rather, reduction of LIP may contribute to IRP-1 enhancement in cooperation with a direct effect of NO. Elucidation of the exact mechanism by which NO affects LIP requires further investigation but, as NO has strong affinity for FeII and yields EPR-detectable complexes with non heme iron in NO-producing or NO-exposed cells (Drapier, 1997; Kennedy et al., 1997; Lancaster et al., 1994) , it can be proposed that formation of such nitrosyl-iron complexes may represent a "sink" for LIP or favor its intracellular transit and/or metabolism. Alternatively, the significance of decreased LIP could be the reduction of the level of the ROS-production catalyst iron as a resistance mechanism in the NO/ROS-producing cells.
In conclusion, our work shows that NOS-2 expression upon inflammatory 
